Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs midazolam + morphine for sedation of mechanically ventilated ICU patients
IRCT20240714062430N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, midazolam and morphine in bronchopulmonary diseases (2 arms), sponsored by Golestan University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
dexmedetomidinemidazolammorphine
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on IRCT20240714062430N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240714062430N1.